$ Value
$0
Shares
1,137,862
Price
$0
Filed
Feb 11
Insider
Name
APPIO THOMAS
Title
Chief Executive Officer
CIK
0001683323
Roles
Transaction Details
Transaction Date
2026-02-09
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,921,111
Footnotes
Reflects performance-based restricted share units ("PSUs"), originally granted to the Reporting Person on March 2, 2023, which were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee of the Board of Directors of the Issuer of the level of achievement of the financial performance metrics applicable to the PSUs for the performance period from January 1, 2023 through December 31, 2025. The PSUs remain subject to a service-based vesting condition through March 2, 2026. Subject to the satisfaction by the Reporting Person of the service-based vesting condition, the Issuer will deliver to the Reporting Person the number of Common Shares earned based on achievement of the financial performance metrics as soon as administratively practicable thereafter.
Filing Info
APPIO THOMAS's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | BHC | F | $498K |
| 2026-03-02 | BHC | J | $6.8M |
| 2026-02-27 | BHC | F | $493K |
| 2026-02-26 | BHC | F | $704K |
| 2026-02-25 | BHC | A | $0 |
| 2026-02-09 | BHC | A | $0 |
Other Insiders at BHC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LEUNG SANDRA | — | — | 2026-03-31 |
| Paulson John | — | — | 2026-03-31 |
| WECHSLER AMY B | — | — | 2026-03-31 |
|
APPIO THOMAS
Chief Executive Officer
|
— | — | 2026-03-02 |
|
Charhon Jean-Jacques
EVP, CFO
|
— | — | 2026-02-27 |
|
LEE STEVEN HYOSIG
SVP, Controller & CAO
|
— | — | 2026-02-25 |
|
Carson Seana
EVP, General Counsel
|
— | $115K | 2026-03-03 |
|
Lenar Aimee J.
EVP, US Pharma
|
— | — | 2026-02-26 |